Cargando…

Proteomics: a new era in pediatric acute myeloid leukemia research

Detalles Bibliográficos
Autores principales:	Lamba, Jatinder K., Pounds, Stanley
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521238/ https://www.ncbi.nlm.nih.gov/pubmed/35021610 http://dx.doi.org/10.3324/haematol.2021.280305

Ejemplares similares

MicroRNAs Mediated Regulation of Expression of Nucleoside Analog Pathway Genes in Acute Myeloid Leukemia
por: Bhise, Neha S., et al.
Publicado: (2019)

Integrated epigenetic and genetic analysis identifies markers of prognostic significance in pediatric acute myeloid leukemia
por: Lamba, Jatinder K., et al.
Publicado: (2018)

Correction: Integrated epigenetic and genetic analysis identifies markers of prognostic significance in pediatric acute myeloid leukemia
por: Lamba, Jatinder K., et al.
Publicado: (2018)

A 6-gene leukemic stem cell score identifies high risk pediatric acute myeloid leukemia
por: Elsayed, Abdelrahman H., et al.
Publicado: (2019)

Global Proteomic Profiling of Pediatric AML: A Pilot Study
por: Nguyen, Nam H. K., et al.
Publicado: (2021)

DNA Methylation‐Based Epigenetic Repression of SLC22A4 Promotes Resistance to Cytarabine in Acute Myeloid Leukemia
por: Buelow, Daelynn R., et al.
Publicado: (2020)

Current Landscape of Genome-Wide Association Studies in Acute Myeloid Leukemia: A Review
por: Marrero, Richard J., et al.
Publicado: (2023)

Current treatment for pediatric acute myeloid leukemia
por: Im, Ho Joon
Publicado: (2018)

Functional Dependency Analysis Identifies Potential Druggable Targets in Acute Myeloid Leukemia
por: Zhou, Yujia, et al.
Publicado: (2020)

SAMHD1 single nucleotide polymorphisms impact outcome in children with newly diagnosed acute myeloid leukemia
por: Marrero, Richard J., et al.
Publicado: (2023)

DNA Methylation Clusters and Their Relation to Cytogenetic Features in Pediatric AML
por: Lamba, Jatinder K., et al.
Publicado: (2020)

Proposal of a new genomic framework for categorization of pediatric acute myeloid leukemia associated with prognosis
por: Umeda, Masayuki, et al.
Publicado: (2023)

Integrative Genomic Analysis of Pediatric Myeloid-Related Acute Leukemias Identifies Novel Subtypes and Prognostic Indicators
por: Fornerod, Maarten, et al.
Publicado: (2021)

The beginning of a new therapeutic era in acute myeloid leukemia
por: Récher, Christian
Publicado: (2021)

MicroRNA–mRNA Pairs Associated with Outcome in AML: From In Vitro Cell-Based Studies to AML Patients
por: Bhise, Neha S., et al.
Publicado: (2016)

Distinct Metabolic features differentiating FLT3-ITD AML from FLT3-WT childhood Acute Myeloid Leukemia
por: Stockard, Bradley, et al.
Publicado: (2018)

Introduction to the Special Issue on Pediatric Acute Myeloid Leukemia: Current Management and Future Directions
por: Stevens, Alexandra M., et al.
Publicado: (2021)

Comparative proteomics in acute myeloid leukemia
por: Luczak, Magdalena, et al.
Publicado: (2012)

CC-PROMISE effectively integrates two forms of molecular data with multiple biologically related endpoints
por: Cao, Xueyuan, et al.
Publicado: (2016)

Fusion genes in acute myeloid leukemia: do acute myeloid leukemia diagnostics need to fuse with RNA-sequencing?
por: Thol, Felicitas
Publicado: (2022)

Chronic myeloid leukemia versus acute myeloid leukemia in patients with retinoblastoma
por: Leahey, Ann-Marie, et al.
Publicado: (2021)

Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges?: Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies
por: Stemler, Jannik, et al.
Publicado: (2022)

Proteomic and phosphoproteomic landscapes of acute myeloid leukemia
por: Kramer, Michael H., et al.
Publicado: (2022)

The Important Role of Immunotherapies in Acute Myeloid Leukemia
por: Greiner, Jochen
Publicado: (2019)

Pulling the Pin on NPMc(+) acute myeloid leukemia
por: Kats, Lev M.
Publicado: (2021)

Will immune therapy cure acute myeloid leukemia?
por: Gale, Robert Peter
Publicado: (2019)

Check(point) or checkmate for acute myeloid leukemia?
por: Niyongere, Sandrine, et al.
Publicado: (2021)

Time to reconsider CD33 single nucleotide polymorphism in the response to gemtuzumab ozogamicin
por: Lamba, Jatinder K., et al.
Publicado: (2021)

Infections in pediatric acute promyelocytic leukemia: from the canadian infections in acute myeloid leukemia research group
por: Cellot, Sonia, et al.
Publicado: (2013)

Expression and functional characterization of CD33 transcript variants in human acute myeloid leukemia
por: Laszlo, George S., et al.
Publicado: (2016)

A new era for proteomics research?
por: Uhlen, Mathias
Publicado: (2008)

A new era for Italian Journal of Pediatrics
por: Bernasconi, Sergio
Publicado: (2008)

Time for Dynamic Assessment of Fitness in Acute Myeloid Leukemia
por: Palmieri, Raffaele, et al.
Publicado: (2022)

Expanding dasatinib beyond KIT in acute myeloid leukemia
por: Welch, John S.
Publicado: (2020)

miRNAs as prognostic predictors in acute myeloid leukemia
por: Machado-Neto, João Agostinho, et al.
Publicado: (2023)

New and Emerging Targeted Therapies for Pediatric Acute Myeloid Leukemia (AML)
por: Chen, Jing, et al.
Publicado: (2020)

Proteomic Characterization of Acute Myeloid Leukemia for Precision Medicine
por: Casado, Pedro, et al.
Publicado: (2023)

Biobanking in the era of precision oncology
por: Saini, Kamal S., et al.
Publicado: (2015)

Long non-coding RNAs emerge as a novel prognostic indicator in pediatric acute myeloid leukemia
por: Velasco-Hernandez, Talia, et al.
Publicado: (2023)

NOX2: a determinant of acute myeloid leukemia survival
por: Jones, Courtney L.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u3mklpbfrou33g9qc4ftt5d0g2